MENU
CYCC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cyclacel Pharmaceuticals (CYCC) Ownership - Who owns Cyclacel Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
846.04K
P/E Ratio
N/A
Total Cash
3.3M
Projected Growth
N/A
Total Debt
21K
Revenue
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash/Share
1.54
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
CYCC
Capitalization
846K
P/E Ratio
N/A
Risk (Beta)
0.06
Dividend Yield
N/A
Total Cash
3.3M
Total Cash/Share
1.54
Total Debt
21K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
N/A
ROE
N/A
Book Value
-2.21M
P/B Ratio
0.85
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
0.58
Current Revenue Per Employee
10714.29
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
N/A
Shares Held By Institutions
361K
Shares Outstanding - Current
2.15M
Total Liabilities
8.37M
Total Volume MTD
N/A
Value
1
Gain YTD
-85.270
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of mechanism-targeted drugs to treat human cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
200 Connell Drive
Phone
+1 908 517-7330
Employees
12
Web
https://cyclacel.com